175 related articles for article (PubMed ID: 30911567)
1. A novel model for treatment of hypertrophic pachymeningitis.
Cui Y; Masaki K; Zhang X; Yamasaki R; Fujii T; Ogata H; Hayashida S; Yamaguchi H; Hyodo F; Eto H; Koyama S; Iinuma K; Yonekawa T; Matsushita T; Yoshida M; Yamada K; Kawano M; Malissen M; Malissen B; Kira J
Ann Clin Transl Neurol; 2019 Mar; 6(3):431-444. PubMed ID: 30911567
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.
Duan WJ; Yu X; Huang XR; Yu JW; Lan HY
Am J Pathol; 2014 Aug; 184(8):2275-84. PubMed ID: 24925688
[TBL] [Abstract][Full Text] [Related]
4. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
7. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
9. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
Zhang S; Liu Q; Xiao J; Lei J; Liu Y; Xu H; Hong Z
Int Immunopharmacol; 2016 May; 34():32-36. PubMed ID: 26919280
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
13. RGS3 inhibits TGF-β1/Smad signalling in adventitial fibroblasts.
Xu F; Liu Y; Shi L; Cai H; Liu W; Hu Y; Li Y; Yuan W
Cell Biochem Funct; 2017 Aug; 35(6):334-338. PubMed ID: 28845525
[TBL] [Abstract][Full Text] [Related]
14. Osteoarthritis-Related Inflammation Blocks TGF-β's Protective Effect on Chondrocyte Hypertrophy via (de)Phosphorylation of the SMAD2/3 Linker Region.
Thielen N; Neefjes M; Wiegertjes R; van den Akker G; Vitters E; van Beuningen H; Blaney Davidson E; Koenders M; van Lent P; van de Loo F; van Caam A; van der Kraan P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360888
[TBL] [Abstract][Full Text] [Related]
15. [Effect and mechnism study of Shengjiyuhong cream on transdifferentiation and collagen production of normal human dermal fibroblasts].
Sun G; Zhang X; Li H; Pan L; Chen Y; Xu K; FEng D
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Sep; 32(5):365-72. PubMed ID: 30066995
[TBL] [Abstract][Full Text] [Related]
16. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
17. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
18. LatY136F knock-in mouse model for human IgG4-related disease.
Yamada K; Zuka M; Ito K; Mizuguchi K; Kakuchi Y; Onoe T; Suzuki Y; Yamagishi M; Izui S; Malissen M; Malissen B; Kawano M
PLoS One; 2018; 13(6):e0198417. PubMed ID: 29902238
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
20. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
